Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium

Eneida R. Nemecek(Oregon Health & Science University), Colleen Delaney(Seattle Children's Hospital), Deidre M. Kiefer(National Marrow Donor Program), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), John E. Levine(Icahn School of Medicine at Mount Sinai), Rabi Hanna(Cleveland Clinic), Paul R. Haut(Indiana University Health), Lauri Burroughs(University of Washington), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Wing Leung(KK Women's and Children's Hospital), Alexia Adams(National Marrow Donor Program), Evelio Perez‐Albuerne(Children's National), Jennifer Le‐Rademacher(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph H. Chewning(Kettering University), Jignesh Dalal(Rainbow Babies & Children's Hospital), Gregory A. Yanik(University of Michigan), Julie‐An Talano(Dana-Farber Cancer Institute), Neena Kapoor(University of Southern California), Aleksandra Petrović(Seattle Children's Hospital), David Delgado(Indiana University Hospital), Roberta H. Adams(Mayo Clinic in Arizona), Ralf A. Hilger(West Cancer Center), Michael A. Pulsipher(Primary Children's Hospital), Stacy Epstein(Carolinas Medical Center), Michael R. Verneris(NHS Blood and Transplant)
Transplantation and Cellular Therapy
May 9, 2018
Cited by 21


Related Papers